Test 4/Week 11: CKD Flashcards

1
Q

CKD Etiology

A

GFR<60 for 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Leading Causes of CKD

A

Hypertension, diabetes

Others: glomerulonephritis, Hypercalcemia, multiple myeloma, chronic UTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CKD Stages

A
GFR
1. >90: normal
2. 60-89: mild
3. 30-59: moderate
4. 15-29: severe, pre-hemodialysis
5 <15: kidney failure, uremia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CKD General signs and symptoms

A

Check creatinine and GFR, hypertension, pulmonary edema

Fatigue, malaise, vision changes, HF, CAD, anorexia, N/V, pruritus, pallor, MS changes, seizures, neuropathy, hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CKD Management/treatment

A

Identify and treat factors associated with the progression of CKD.

Dialysis, HTN, glucose control, anemia, hyperlipidemia, transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Target BP

A

<130/80

<125/75 with proteinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Best predictor of CKD progression

A

Proteinuria

Normal albumin excretion: <30mg/day
Nephrotic: >3g/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CKD metabolic changes

A

Down: H/H, bicarb, calcium, sodium

Up: phosphate, PTH, triglycerides, creatinine, potassium

Leads to acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hematologic changes

A

Anemia (decreased erythropoietin and platelet function), leukocyte function, humoral/cellular response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Epoetin alfa (Epogen/Procrit) Treatment

A

Hemodialysis: 50-109 units/kg IV/SC 3x/wk

Non-hemodialysis: 10,000 units/week

AE: iron deficiency and constipation from iron treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Darbepoetin alfa (Aranesp) Treatment

A

HD: 0.45 mcg/kg weekly

Non-HD: 60 mcg q2wks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metabolic acidosis

A

Leads to release of bone calcium/phosphorus, muscle catabolism (decreased albumin synthesis), maintain bicarb>22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CKD Nutrition Restrictions

A

Restrict: protein, water (1-3kg between dialysis), sodium (2-4g), potassium (2-3g), phosphate (1g)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hemodialysis assessment/priorities

A

ABCs, temperature before starting, current medications, how much fluid was taken off

complete assessment with heart and lung sounds, condition of access, weight, BP, edema, labs, CXR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Arteriovenous Fistula Types

A
  1. Radiocephalic
  2. Brachiocephalic
  3. Brachiobasilic
  4. Rare in lower extremities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

AVF Assessment

A

Look: condition, infection
Feel: for thrill, pulse is bad
Listen: low pitched bruit, high pitched/short is bad

17
Q

Arteriovenous Grafts

A

Synthetic conduit between artery/vein, straight or looped

18
Q

3 Phases of PD

A

Called an exchange: inflow (fill), dwell (equilibration), drain

19
Q

Inflow Phase of PD

A

Prescribed amount of solution infused through catheter over 10 minutes. After infused inflow clamp is closed to prevent air from entering tubing

20
Q

Dwell Phase of PD

A

Diffusion/osmosis occur between blood and peritoneal cavity, duration varies

21
Q

Drain Phase of PD

A

15-30 minutes, facilitated by gently massaging abdomen/position changes

Call MD for any drainage at insertion site

22
Q

PD Management/Assessment

A

Maintain sterile environment, mask/gloves, sterile tubing, skin cleansing/sterile dressing

VS q 30-60mins, watch for changes in LoC, post treatment weight

23
Q

PD Complications

A

Hypotension, muscle cramping

Blood loss, hepatitis, sepsis

24
Q

Collaboration with Dialysis Nurse

A

Hold meds? BP, ABx, diuretics, analgesics

Lab results, device assessment